Stoke Therapeutics, Inc.
DE ˙ DB ˙ US86150R1077
24,23 € ↓ -0,45 (-1,82%)
2026-06-05
DEL PRIS
SecurityDE:0GT / Stoke Therapeutics, Inc.
InstitutionRhumbline Advisers
Latest Disclosed Ownership67,315 shares
Latest Disclosed Value $ 2,191,765
Rhumbline Advisers reports 7.85% increase in ownership of 0GT / Stoke Therapeutics, Inc.

On May 12, 2026 - Rhumbline Advisers filed a 13F-HR form disclosing ownership of 67,315 shares of Stoke Therapeutics, Inc. (DE:0GT) valued at $1,844,431 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 62,414 shares of Stoke Therapeutics, Inc.. This represents a change in shares of 7.85% during the quarter. The current value of the position is $1,631,042 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F STOKE THERAPEUTICS COM 86150R107 67,315 4,901 7.85 2,192 10.60 0.0019
2026-02-13 2025-12-31 13F STOKE THERAPEUTICS COM 86150R107 62,414 -5,890 -8.62 1,981 23.43 0.0016
2025-11-06 2025-09-30 13F STOKE THERAPEUTICS COM 86150R107 68,304 1,885 2.84 1,605 113.15 0.0013
2025-08-12 2025-06-30 13F STOKE THERAPEUTICS COM 86150R107 66,419 16,820 33.91 754 128.88 0.0006
2025-05-29 2025-03-31 13F/A-1 STOKE THERAPEUTICS COM 86150R107 49,599 225 0.46 330 -39.52 0.0003
2025-04-08 2025-03-31 13F STOKE THERAPEUTICS COM 86150R107 49,599 225 330 0.0003
2025-05-29 2024-12-31 13F/A-1 STOKE THERAPEUTICS COM 86150R107 49,374 2,787 5.98 545 -4.90 0.0005
2025-01-30 2024-12-31 13F STOKE THERAPEUTICS COM 86150R107 49,374 2,787 545 0.0005
2024-11-12 2024-09-30 13F STOKE THERAPEUTICS COM 86150R107 46,587 -1,273 -2.66 573 -11.46 0.0005
2024-08-01 2024-06-30 13F STOKE THERAPEUTICS COM 86150R107 47,860 5,990 14.31 647 14.34 0.0006
2024-05-09 2024-03-31 13F STOKE THERAPEUTICS COM 86150R107 41,870 899 2.19 565 162.79 0.0005
2024-02-08 2023-12-31 13F STOKE THERAPEUTICS COM 86150R107 40,971 -38 -0.09 215 33.54 0.0002
2023-11-09 2023-09-30 13F STOKE THERAPEUTICS COM 86150R107 41,009 -1,166 -2.76 162 -64.06 0.0002
2023-08-08 2023-06-30 13F STOKE THERAPEUTICS COM 86150R107 42,175 7,578 21.90 448 0.0005
2023-05-11 2023-03-31 13F STOKE THERAPEUTICS COM 86150R107 34,597 406 1.19 0 -100.00 0.0004
2023-02-14 2022-12-31 13F STOKE THERAPEUTICS COM 86150R107 34,191 475 1.41 316 -27.02 0.0004
2022-11-10 2022-09-30 13F STOKE THERAPEUTICS COM 86150R107 33,716 1,865 5.86 433 2.85 0.0006
2022-08-11 2022-06-30 13F STOKE THERAPEUTICS COM 86150R107 31,851 12,506 64.65 421 3.44 0.0006
2022-05-12 2022-03-31 13F STOKE THERAPEUTICS COM 86150R107 19,345 1,362 7.57 407 -5.57 0.0005
2022-02-10 2021-12-31 13F STOKE THERAPEUTICS COM 86150R107 17,983 -336 -1.83 431 -7.51 0.0005
2021-11-12 2021-09-30 13F STOKE THERAPEUTICS COM 86150R107 18,319 849 4.86 466 -20.75 0.0006
2021-08-05 2021-06-30 13F STOKE THERAPEUTICS COM 86150R107 17,470 1,963 12.66 588 -2.33 0.0008
2021-05-06 2021-03-31 13F STOKE THERAPEUTICS COM 86150R107 15,507 -165 -1.05 602 -38.00 0.0008
2021-02-10 2020-12-31 13F STOKE THERAPEUTICS COM 86150R107 15,672 910 6.16 971 96.56 0.0013
2020-11-12 2020-09-30 13F STOKE THERAPEUTICS COM 86150R107 14,762 -2,115 -12.53 494 22.89 0.0008
2020-08-13 2020-06-30 13F STOKE THERAPEUTICS COM 86150R107 16,877 -3,341 -16.52 402 -13.17 0.0007
2020-05-06 2020-03-31 13F STOKE THERAPEUTICS COM 86150R107 20,218 12,279 154.67 463 105.78 0.0010
2020-02-05 2019-12-31 13F STOKE THERAPEUTICS COM 86150R107 7,939 7,939 225 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.